<DOC>
	<DOCNO>NCT00289042</DOCNO>
	<brief_summary>SPECIFIC AIM : To test safety feasibility use low molecular weight heparin ( LMWH , enoxaparin sodium ; Lovenox , Sanofi-Aventis ) lieu unfractionated heparin ( UFH ) antithrombotic therapy patient atrial fibrillation undergo transesophageal echocardiography ( TEE ) guide chemical electrical cardioversion sinus rhythm . HYPOTHESIS : Early cardioversion atrial fibrillation safely perform use short-term anticoagulation strategy low molecular weight heparin ( Lovenox , Sanofi-Aventis ) compare unfractionated heparin , accompany TEE examination prior cardioversion . The use LMWH TEE result safe , cost-effective , possible efficacious approach cardioversion atrial fibrillation compare UFH TEE .</brief_summary>
	<brief_title>Assessment Cardioversion Using Transesophageal Echocardiography II ( ACUTE II )</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Patients chronic paroxysmal atrial fibrillation &gt; 2 day duration candidate early chemical electrical cardioversion Patients atrial flutter document history ( electrocardiography ) atrial fibrillation Males females 18 year age old Patients available result routine clinical lab standard clinical chemistry complete blood count within previous 14 day An INR &gt; 1.4 patient receive warfarin prior enrollment . Use IV heparin 72 hour immediately prior randomization . Patients contraindication TEE , dysphagia , esophageal stricture . Patients need anticoagulation discontinue elective intervening procedure , cardiac catheterization surgery . Patients contraindication warfarin heparin Patients require concomitant therapy study period drug know affect coagulation platelet function ( i.e . ASA , NSAID , antiplatelet drug ) Women childbearing potential , unless pregnancy exclude medical history incompatible pregnancy serum urine beta HCG level . Patients hemodynamically unstable thus may require immediate cardioversion . Weight le 40 kg ( 88 pound ) 125 kg ( 275 pound ) History gastrointestinal bleeding disorder and/or endoscopically verified ulcer disease within last year History intracranial retinal bleeding , know disorder increase risk bleed Ischemic stroke previous three month Uncontrolled hypertension ( systolic blood pressure great 180 mm Hg diastolic blood pressure great 100 mm Hg ) Malignancy currently active treatment , include melanoma Patients renal insufficiency ( creatinine &gt; 2.0 mg/dL ) renal transplant subject Patients anemia ( Hgb le 10 gm/dL ) Patients thrombocytopenia ( platelet count le 100 x 10^9/L ) Positive fecal hemoglobin test Life expectancy le 6 month History drug and/or alcohol abuse within last two year Patients unable unwilling give inform consent Patients unable unwilling return followup Prisoners ward state Patients psychological problem may decrease compliance protocol Not willing complete Quality Life Questionnaires x 3 Participating another clinical trial and/or take investigational medication past 30 day Patient language , learn skill , home environment unconducive selfmanagement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2005</verification_date>
	<keyword>atrial fibrillation</keyword>
	<keyword>atrial thrombus</keyword>
	<keyword>cardioversion</keyword>
	<keyword>enoxaparin</keyword>
	<keyword>low molecular weight heparin</keyword>
	<keyword>transesophageal echocardiography</keyword>
</DOC>